This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, United Kingdom, South Africa
The drug MOVIPREP contains a combination of these active pharmaceutical ingredients (APIs):
1
Macrogol 3350
UNII G2M7P15E5P - POLYETHYLENE GLYCOL 3350
|
High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids. |
2
Sodium sulfate
UNII 36KCS0R750 - SODIUM SULFATE ANHYDROUS
|
Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions. |
3
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
4
Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
5
Ascorbic acid
UNII PQ6CK8PD0R - ASCORBIC ACID
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
6
Sodium ascorbate
UNII S033EH8359 - SODIUM ASCORBATE
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MOVIPREP Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A06AD65 | Macrogol, combinations | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02359499 |
Country: EE | Ravimiamet | Identifier(s): 1479416, 1479427, 1479438, 1479449, 1479450, 1479461 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 340093781647, 68125, 73642 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 075187 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61095956 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 113805, 113808, 113811, 182439, 182442 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-033715132 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6679 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7990102A1024 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1054742, 1054743, 1058559, 1058560, 1058561, 1058562, 1058563 |
Country: MT | Medicines Authority | Identifier(s): MA930/00101 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 83291 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 12733, 18009 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100248228, 100404272, 100449211, 100456020 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66152001, W66152002, W66152003, W66152004, W66152005, W66152006 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 42/11.5/0407 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.